News

 

 

Funding: New Awards

New Awards

Carmen J. Marsit, PhD
Member, Cancer Epidemiology and Chemoprevention Research Program at Norris Cotton Cancer Center, and Assistant Professor of Pharmacology & Toxicology and of Community and Family Medicine at Dartmouth Medical School

  • National Institutes of Mental Health
    Epigenetics in neurodevelopment and mental health
    R01

James Moseley, PhD
Member, Cancer Mechanisms Research Program at Norris Cotton Cancer Center, and Assistant Professor of Biochemistry at Dartmouth Medical School

  • National Institute of General Medical Sciences (NIH)
    Mechanisms that coordinate cell size with mitotic entry
    R01
New Clinical Trials

Alexey V. Danilov, MD, PhD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center, and Visiting Scientist, Medicine, at Dartmouth Medical School

  • NIH
    A study of the effect of MEK inhibitor GSK1120212 on p63 expression and keratinocyte differentiation in human skin
  • NCI
    A study of the effect of vinca alkaloids on JNK phosphorylation status in patients with chronic lymphocytic leukemia (CLL)

Marc Ernstoff, MD
Member, Immunology and Cancer Immunotherapy Research Program at Norris Cotton Cancer Center, and Professor of Medicine at Dartmouth Medical School

  • Bristol Myers Squibb
    A Phase 1 study of BMS-936558 plus sunitinib or pazopanib in subjects with metastatic renal cell carcinoma

Carmen J. Marsit, PhD
Member, Cancer Epidemiology and Chemoprevention Research Program at Norris Cotton Cancer Center, and Assistant Professor of Pharmacology & Toxicology at Dartmouth Medical School

  • PI/department funding
    Bladder tumor tissue bank

J. Marc Pipas, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center, and Associate Professor of Medicine at Dartmouth Medical School

  • Peregrine Pharmaceuticals, Inc
    A randomized, open-label, Phase 2 trial of gemcitabine with or without bavituximab in patients with previously untreated stage IV pancreatic cancer